Valuation Charles River Laboratories International, Inc. Berne S.E.

Stocks

End-of-day quote Berne S.E. 2026-08-14			5-day change	1st Jan Change
225.03 ^CHF	-2.88%		+5.49%	-

Aug. 13	Charles River Laboratories International Insider Sold Shares Worth $1,038,657, According to a Recent SEC Filing	MT
Aug. 10	TD Cowen Adjusts PT on Charles River Laboratories International to $300 From $235, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	13,369	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	33.38%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	15,482	15,000	14,606
Change	-	-36.28%	7.39%	-20.91%	3.29%	29.6%	-3.11%	-2.62%
P/E	49.4x	23.1x	25.9x	931x	-70x	74.9x	30x	26.8x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	4.44x	3.77x	3.35x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0x	2.3x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	3.42x	3.34x	3.18x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	3.96x	3.75x	3.47x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	15.4x	13.7x	12.4x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	18.9x	16.4x	14.6x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	49.1x	24.6x	30.6x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	2.04%	4.06%	3.27%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	3.738	9.346	10.43
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,911	4,001	4,208
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	1,008	1,093	1,174
EBIT ¹	742.1	834	838.8	805.9	793.9	821	912.3	1,001
Net income ¹	391	486.2	474.6	10.3	-144.3	162.5	427.8	471.2
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	2,112	1,631	1,237
Reference price ²	375.34	218.92	238.84	186.16	203.66	280.05	280.05	280.05
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	47,739	-	-
Announcement Date	2/16/22	2/22/23	2/14/24	2/19/25	2/18/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	33.04x	5.91x	17.56x	0.97%	48.42B
REVOLUTION MEDICINES, INC.	-21.14x	288.75x	-21.43x	-.--%	43.66B
BEONE MEDICINES AG	45.52x	5.25x	28.69x	-.--%	39.51B
IQVIA HOLDINGS INC.	30.48x	3.03x	13.08x	-.--%	38.95B
CELLTRION, INC.	30.58x	8.82x	22.17x	0.38%	32.61B
MEDPACE HOLDINGS, INC.	32.9x	5.38x	24.45x	-.--%	16.15B
EUROFINS SCIENTIFIC SE	23.48x	2.05x	8.89x	1.15%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.93x	3.96x	15.35x	-.--%	13.37B
Average	31.22x	40.39x	13.59x	0.31%	30.85B
Weighted average by Cap.	26.43x	55.41x	12.18x	0.31%